Cotrimoxazole for childhood febrile illness in malaria-endemic regions
Malawi med. j. (Online)
;
8(1): 29-30, 1992.
Article
in English
| AIM
| ID: biblio-1265324
ABSTRACT
The efficacy of co-trimaxozole for the treatment of Plasmodium falciparum parasitaemia in children younger than 5 years of age was evaluated in Malawi. 46 children with P falciparum parasitaemia; 37 percent of whom also met clinical criteria for acute respiratory tract infection; were treated with 20 mg/kg co-trimaxozole twice daily for five days. Parasitaemia (mean clearance time 2.7 days) and syptoms were rapidly abolished and improvement was maintained during the follow-up 14 days. Co-trimaxozole may be an effecitve single treatment for febrile illness in young children in areas where malaria is endemic; resources are few; and diagnosis must rely on clinical findings alone
Search on Google
Index:
AIM (Africa)
Main subject:
Plasmodium falciparum
/
Respiratory Tract Infections
/
Child
/
Drug Therapy
/
Malaria
/
Anti-Bacterial Agents
Language:
English
Journal:
Malawi med. j. (Online)
Year:
1992
Type:
Article
Similar
MEDLINE
...
LILACS
LIS